Hong Kong’s Hang Seng Index fell 0.14% by midday on October 27, 2026, amid mixed sector performances and lingering concerns over global market dynamics, according to Xinhua and The Standard (HK).
Early Market Volatility
Hong Kong’s Hang Seng Index edged down 0.3% to 23,138 points in early trading on October 27, marking a modest decline as investors weighed optimism around AI-related stocks against broader economic headwinds. The benchmark index had previously fallen as much as 3% on October 2, the steepest drop since March 23, driven by rising U.S. yields and disappointment over China’s stimulus measures, according to Bloomberg.
The Hang Seng Tech Index closed the morning session at 3,845 points, down 0.3%, according to The Standard (HK). The index was poised to end a three-session losing streak if momentum persisted, though broader market sentiment remained cautious. Meanwhile, Japan’s Nikkei rose 1.91% to 63,374.45, after previously climbing as much as 2.4% during the session, per the same source.
Sector-Specific Movements
The tech sector faced pressure, with the Hang Seng Tech Index down 0.77% as companies like Xiaomi and Meituan declined. Meanwhile, financials dragged the market, with HSBC Holdings Plc falling 5.7% amid broader sector weakness.

Pharmaceutical stocks declined broadly, with news.futunn.com noting that Hutchison China MediTech fell 5.14%, Sansheng Biopharma dropped 4.96%, Hengrui Pharma slipped 4.41%, CSPC Pharma declined 3.22%, Hansoh Pharma fell 3.04%, Sino Biopharm edged down 1.93%, Innovent Bio retreated 1.81%, and Insilico Medicine fell 1.21%. Semiconductor stocks advanced, with several companies posting gains.
The Hang Seng China Enterprises Index fell 0.35% by midday, per news.futunn.com. As of the midday close, 813 Hong Kong stocks advanced, 1,176 declined, and 1,349 closed unchanged, according to the same source. Notable losers included Duality Biotherapeutics (-21.9%), Xiaomi (-2.3%), Meituan (-1.5%), Akeso (-1.4%), and Wuxi Biologics (-1.1%), as reported by Bloomberg.

Global Context and Investor Sentiment
Global markets showed mixed signals, with Japan’s Nikkei rising 1.91% and Brent crude slipping amid diplomatic efforts to ease U.S.-Iran tensions. Investors also awaited HSBC’s earnings report for further insights into banking sector health. Concerns over Meta’s $95 billion AI investment plan lingered.
Spot gold dipped 0.1% to $4,013.70 per ounce, while U.S. gold futures fell 0.3% to $4,027.10, reflecting broader commodity market adjustments.
The Hang Seng Index closed the morning session at 23,180.40, down 31.41 points or 0.14%, according to News. Financials were a major drag, with shares of HSBC Holdings Plc slumping 5.7%, as reported by Bloomberg. A gauge of Chinese equities listed in Hong Kong was down more than 2%, with markets in mainland China closed for holidays, removing a potential source of buying support.